| Literature DB >> 30128212 |
Pengpeng Wang1, Shengguo Zhao1, Xuemei Nan1, Di Jin1, Jiaqi Wang1.
Abstract
The objective of this experiment was to evaluate the effects of urea hydrolysis rate on ruminal bacterial diversity level and cellulolytic bacteria abundance in vitro. To control urea hydrolysis rate, urea and urease inhibitor (acetohydroxamic acid, AHA) were supplemented to a 2 × 2 factorial design, with urea supplemented at 0 or 20 g/kg dry matter (DM) of substrate, and AHA equivalent to 0 or 450 mg/kg DM of substrate. Ruminal fluid was collected from three Chinese Holstein dairy cows, fed a TMR, and incubated at 39 °C for 12 h after the addition of urea and AHA. Rumen fermentation parameters, which indicated the rate of ammonia formation (including ammonia-nitrogen (NH3-N) and urea-nitrogen concentrations, urease activity, and microbial crude protein) were measured by chemical analysis. Bacterial diversity was analyzed by denaturing gradient gel electrophoresis (DGGE). Total bacteria and cellulolytic bacteria abundance was detected by quantitative PCR. Results showed that AHA addition significantly decreased the rate of ammonia formation when urea was supplemented. Urea and AHA supplementation significantly increased the bacterial community diversity level according to the Shannon-Weiner index of 16S DGGE images. Furthermore, ruminal bacterial profiles were separated by ammonia release rate when urea was supplemented, according to the DGGE and hierarchical cluster analysis. Urea supplementation reduced the abundance of cellulolytic bacteria, such as Ruminococcus albus, R. flavefaciens, Fibrobacter succinogenes, and Butyrivibrio fibrosolvens, but inhibition of urea hydrolysis by AHA addition alleviated the reductions during the early period of incubation. In conclusion, slow release of ammonia induced by urease inhibitor influenced the ruminal bacterial diversity level and lessened the inhibition of total bacteria growth at the incubation of 12 h and F. succinogenes during the early period of incubation.Entities:
Keywords: Acetohydroxamic acid; Ammonia; Bacterial community; Cellulolytic bacteria; Urea
Year: 2018 PMID: 30128212 PMCID: PMC6100864 DOI: 10.7717/peerj.5475
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
The primers used in qPCR.
| Item | Primer sequence (5′–3′) | Product size (bp) | Efficiency (%) | Reference |
|---|---|---|---|---|
| Total bacteria | F: CGGCAACGAGCGCAACCC | 146 | 92.3 | |
| F: CCCTAAAAGCAGTCTTAGTTCG | 176 | 93.1 | ||
| F: GAACGGAGATAATTTGAGTTTACTTAGG | 132 | 94.8 | ||
| F: GTTCGGAATTACTGGGCGTAAA | 121 | 96.4 | ||
| F: TAACATGAGAGTTTGATCCTGGCTC | 136 | 93.9 |
Effects of urea and urease inhibitor supplementation on temporal changes of ammonia-nitrogen (NH3-N) and urea-nitrogen (Urea-N) concentrations, urease activity, and microbial crude protein (MCP) after 12 h of incubation in vitro.
| Item | Culture time (h) | Treatment | SEM | ||||||
|---|---|---|---|---|---|---|---|---|---|
| U0UI0 | U0UI450 | U2UI0 | U2UI450 | Urea | AHA | Urea × AHA | |||
| NH3-N concentrations (mg/100 ml) | 0.5 | 18.64 | 17.94 | 21.75 | 19.99 | 0.971 | 0.03 | 0.24 | 0.60 |
| 1 | 16.00 | 15.62 | 26.72 | 18.34 | 1.338 | <0.01 | 0.01 | 0.02 | |
| 2 | 17.50 | 17.24 | 28.97 | 24.33 | 0.627 | <0.01 | <0.01 | <0.01 | |
| 4 | 17.91 | 16.09 | 24.30 | 24.49 | 2.060 | <0.01 | 0.71 | 0.64 | |
| 6 | 12.74 | 15.54 | 21.95 | 23.85 | 2.012 | <0.01 | 0.28 | 0.83 | |
| 12 | 17.70 | 16.32 | 28.09 | 26.57 | 1.315 | <0.01 | 0.30 | 0.96 | |
| Urease activity (nmol/min/mg) | 0.5 | 2.26 | 1.91 | 4.92 | 3.10 | 0.511 | 0.01 | 0.08 | 0.19 |
| 1 | 2.28 | 1.58 | 4.97 | 2.40 | 0.908 | 0.06 | 0.07 | 0.27 | |
| 2 | 2.56 | 1.80 | 5.16 | 3.32 | 0.540 | <0.01 | 0.04 | 0.32 | |
| 4 | 2.66 | 1.67 | 4.45 | 4.04 | 0.388 | <0.01 | 0.21 | 0.34 | |
| 6 | 1.50 | 1.58 | 3.42 | 3.26 | 0.152 | <0.01 | 0.80 | 0.47 | |
| 12 | 1.58 | 2.40 | 3.34 | 2.66 | 0.414 | 0.07 | 0.87 | 0.14 | |
| Urea-N concentrations (μmol) | 0.5 | 0 | 0 | 44.20 | 45.10 | 0.199 | – | 0.56 | – |
| 1 | 0 | 0 | 0 | 44.63 | 0.702 | – | <0.01 | – | |
| 2 | 0 | 0 | 0 | 37.74 | 0.834 | – | <0.01 | – | |
| 4 | 0 | 0 | 0 | 31.45 | 1.921 | – | <0.01 | – | |
| 6 | 0 | 0 | 0 | 17.57 | 1.814 | – | <0.01 | – | |
| 12 | 0 | 0 | 0 | 0 | 0 | – | – | – | |
| MCP (mg/100 ml) | 12 | 1.13 | 1.13 | 1.21 | 1.19 | 0.074 | 0.40 | 0.91 | 0.90 |
Notes:
Treatments consisted of substrate (U0UI0), substrate with AHA addition (U0UI450), substrate with urea supplementation (U2UI0), and substrate with both AHA and urea supplementation (U2UI450).
SEM is standard error of the means.
Means treatments are different significantly in the same row.
Figure 1Effects of urea and urease inhibitor (acetohydroxamic acid, AHA) supplementation on bacterial diversity at 0, 4, and 12 h of incubation analysis by DGGE.
Treatments without urea supplementation were grouped together to form a cluster (U0), which was separated from the treatments with urea supplementation (U2). Treatments with urea supplementation were further separated according to the AHA addition (U2UI0 vs. U2UI450). The ruminal bacterial profiles were separated by ammonia release rate when urea was supplemented, according to the DGGE and hierarchical cluster analysis.
Effects of urea and urease inhibitor supplementation on the populations of ruminal cellulolytic bacteria at 0.5, 4, and 12 h of incubation in vitro.
| Item | Culture time (h) | Treatment | SEM | ||||||
|---|---|---|---|---|---|---|---|---|---|
| U0UI0 | U0UI450 | U2UI0 | U2UI450 | Urea | AHA | Urea × AHA | |||
| Total bacteria (log10 copies per ml) | 0.5 | 8.22 | 7.96 | 7.77 | 7.97 | 0.085 | 0.01 | 0.74 | 0.01 |
| 4 | 8.11 | 8.35 | 8.29 | 8.14 | 0.067 | 0.87 | 0.53 | 0.01 | |
| 12 | 8.04 | 8.19 | 7.93 | 8.08 | 0.079 | 0.16 | 0.06 | 0.95 | |
| 0.5 | 5.84 | 5.95 | 5.50 | 5.65 | 0.080 | 0.02 | 0.09 | 0.75 | |
| 4 | 5.41 | 5.48 | 5.42 | 5.29 | 0.083 | 0.24 | 0.67 | 0.19 | |
| 12 | 5.11 | 5.12 | 4.85 | 4.94 | 0.131 | 0.09 | 0.69 | 0.78 | |
| 0.5 | 5.12 | 4.94 | 4.32 | 4.62 | 0.108 | <0.01 | 0.56 | 0.03 | |
| 4 | 4.31 | 4.64 | 4.48 | 4.54 | 0.096 | 0.68 | 0.03 | 0.13 | |
| 12 | 3.97 | 3.87 | 3.29 | 3.54 | 0.130 | <0.01 | 0.51 | 0.15 | |
| 0.5 | 7.03 | 7.06 | 6.75 | 7.05 | 0.081 | 0.05 | 0.03 | 0.07 | |
| 4 | 7.13 | 7.13 | 7.04 | 7.03 | 0.050 | 0.06 | 0.90 | 0.92 | |
| 12 | 7.14 | 7.10 | 6.89 | 6.87 | 0.102 | 0.04 | 0.71 | 0.98 | |
| 0.5 | 7.82 | 7.68 | 7.47 | 7.56 | 0.037 | <0.01 | 0.49 | <0.01 | |
| 4 | 7.55 | 7.66 | 7.48 | 7.56 | 0.033 | 0.01 | <0.01 | 0.69 | |
| 12 | 7.67 | 7.74 | 7.52 | 7.66 | 0.056 | 0.05 | 0.07 | 0.57 | |
Notes:
Treatments consisted of substrate (U0UI0), substrate with AHA addition (U0UI450), substrate with urea supplementation (U2UI0), and substrate with both AHA and urea supplementation (U2UI450).
SEM is standard error of the mean.
Means treatments are different significantly in the same row.